Compare EHang Holdings Ltd - ADR (EH) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EHang Holdings Ltd - ADR vs Recursion Pharmaceuticals Inc — how do they compare? EHang Holdings Ltd - ADR trades at $5.51 (market cap $414.87M), while Recursion Pharmaceuticals Inc trades at $3.2 (market cap $1.75B). The key difference: Recursion Pharmaceuticals Inc is far larger — about 4.2× EHang Holdings Ltd - ADR's market cap. Which is the better fit depends on your goals.
| EH | RXRX | |
|---|---|---|
Market Cap | $414.87M | $1.75B |
Sector | Industrials | Health |
52-Week High | $19.99 | $6.79 |
52-Week Low | $5.41 | $2.84 |
Enterprise Value | $354.54M | $1.17B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EHang Holdings (EH) trades at $5.56, up 2.02% on the day, amid mixed technical and fundamental signals. The stock shows a bearish technical trend with oversold short-term RSI, while fundamentally, the company reported Q1 2026 revenue of $418M, flat year-over-year but sharply lower sequentially due to delivery timing. The company remains unprofitable with a net margin of -77.56% and negative ROE of -34.03%, though it maintains a strong cash position of $1.12B and recently announced a $30M share repurchase program.
The outlook is bifurcated between significant long-term potential in the advanced air mobility market and near-term execution and profitability challenges. Investment opportunity lies in the company's first-mover technology and global regulatory progress, but risks include persistent cash burn, high valuation multiples despite losses, and intense competition in the emerging eVTOL sector. Analyst consensus is divided with a $6.97 price target but equal buy/hold/sell ratings.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About EHang Holdings Ltd - ADR
EHang Holdings Ltd is an autonomous aerial vehicle (AAV) technology platform company. It focuses on making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management and aerial media solutions. As the forerunner of cutting-edge AAV technologies and commercial solutions in the global Urban Air Mobility industry, it continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
Read more on EH →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
